These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 34427302)
1. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy. Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy: A Multicenter International Ventricular Tachycardia Registry. Santangeli P; Tung R; Xue Y; Chung FP; Lin YJ; Di Biase L; Zhan X; Lin CY; Wei W; Mohanty S; Burkhardt DJ; Zado ES; Callans DJ; Marchlinski FE; Wu S; Chen SA; Natale A JACC Clin Electrophysiol; 2019 Jan; 5(1):55-65. PubMed ID: 30678787 [TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy. Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378 [TBL] [Abstract][Full Text] [Related]
4. Clinical course of arrhythmogenic right ventricular cardiomyopathy in the era of implantable cardioverter-defibrillators and radiofrequency catheter ablation. Komura M; Suzuki J; Adachi S; Takahashi A; Otomo K; Nitta J; Nishizaki M; Obayashi T; Nogami A; Satoh Y; Okishige K; Hachiya H; Hirao K; Isobe M Int Heart J; 2010 Jan; 51(1):34-40. PubMed ID: 20145349 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes of Radio-Frequency Catheter Ablation on Ventricular Tachycardias Due to Arrhythmogenic Right Ventricular Cardiomyopathy: A Single Center Experience. Wei W; Liao H; Xue Y; Fang X; Huang J; Liu Y; Deng H; Liang Y; Liao Z; Liu F; Lin W; Zhan X; Wu S PLoS One; 2017; 12(1):e0169863. PubMed ID: 28122031 [TBL] [Abstract][Full Text] [Related]
6. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. Maury P; Baratto F; Zeppenfeld K; Klein G; Delacretaz E; Sacher F; Pruvot E; Brigadeau F; Rollin A; Andronache M; Maccabelli G; Gawrysiak M; Brenner R; Forclaz A; Schlaepfer J; Lacroix D; Duparc A; Mondoly P; Bouisset F; Delay M; Hocini M; Derval N; Sadoul N; Magnin-Poull I; Klug D; Haïssaguerre M; Jaïs P; Della Bella P; De Chillou C Eur Heart J; 2014 Jun; 35(22):1479-85. PubMed ID: 24536081 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death. Yin K; Ding L; Li Y; Hua W Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837 [TBL] [Abstract][Full Text] [Related]
8. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259 [TBL] [Abstract][Full Text] [Related]
9. Ten-year outcomes of monomorphic ventricular tachycardia catheter ablation in repaired tetralogy of Fallot. Laredo M; Frank R; Waintraub X; Gandjbakhch E; Iserin L; Hascoët S; Himbert C; Gallais Y; Hidden-Lucet F; Duthoit G Arch Cardiovasc Dis; 2017 May; 110(5):292-302. PubMed ID: 28347634 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). Romero J; Grushko M; Briceño DF; Natale A; Di Biase L Curr Cardiol Rep; 2017 Sep; 19(9):82. PubMed ID: 28779285 [TBL] [Abstract][Full Text] [Related]
11. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of ICD electrograms analysis to distinguish endocardial vs epicardial ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Kodali S; Shirai Y; Callans DJ; Zado ES; Marchlinski FE; Santangeli P J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1526-1534. PubMed ID: 31187564 [TBL] [Abstract][Full Text] [Related]
13. Catheter ablation of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy. Laredo M; Oliveira Da Silva L; Extramiana F; Lellouche N; Varlet É; Amet D; Algalarrondo V; Waintraub X; Duthoit G; Badenco N; Maupain C; Hidden-Lucet F; Maury P; Gandjbakhch E; Heart Rhythm; 2020 Jan; 17(1):41-48. PubMed ID: 31284048 [TBL] [Abstract][Full Text] [Related]
14. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Philips B; te Riele AS; Sawant A; Kareddy V; James CA; Murray B; Tichnell C; Kassamali B; Nazarian S; Judge DP; Calkins H; Tandri H Heart Rhythm; 2015 Apr; 12(4):716-25. PubMed ID: 25530221 [TBL] [Abstract][Full Text] [Related]
15. Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome. Cheng WH; Chung FP; Lin YJ; Lo LW; Chang SL; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang TY; Kuo L; Wu CI; Liu CM; Liu SH; Chen SA Rev Cardiovasc Med; 2021 Dec; 22(4):1295-1309. PubMed ID: 34957771 [TBL] [Abstract][Full Text] [Related]
16. Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Sequential Approach. Mathew S; Saguner AM; Schenker N; Kaiser L; Zhang P; Yashuiro Y; Lemes C; Fink T; Maurer T; Santoro F; Wohlmuth P; Reißmann B; Heeger CH; Tilz R; Wissner E; Rillig A; Metzner A; Kuck KH; Ouyang F J Am Heart Assoc; 2019 Mar; 8(5):e010365. PubMed ID: 30813830 [TBL] [Abstract][Full Text] [Related]
17. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion. Honarbakhsh S; Protonotarios A; Monkhouse C; Hunter RJ; Elliott PM; Lambiase PD Europace; 2023 May; 25(5):. PubMed ID: 37213071 [TBL] [Abstract][Full Text] [Related]
18. Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy. Assis FR; Tandri H Card Electrophysiol Clin; 2020 Sep; 12(3):329-343. PubMed ID: 32771187 [TBL] [Abstract][Full Text] [Related]
19. Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations. AbdelWahab A; Gardner M; Parkash R; Gray C; Sapp J J Cardiovasc Electrophysiol; 2018 Jan; 29(1):90-97. PubMed ID: 28960618 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation. Kirubakaran S; Bisceglia C; Silberbauer J; Oloriz T; Santagostino G; Yamase M; Maccabelli G; Trevisi N; Della Bella P Europace; 2017 Jun; 19(6):1049-1062. PubMed ID: 28371837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]